Skip to main content
Evotec SE logo

Evotec SE — Investor Relations & Filings

Ticker · EVT ISIN · DE0005664809 LEI · 529900F9KI6OYITO9B12 F Professional, scientific and technical activities
Open in API
Filings indexed 1,778 across all filing types
Latest filing 2006-11-09 Interim / Quarterly Rep…
Country DE Germany
Listing F EVT

About Evotec SE

https://www.evotec.com/en

Evotec SE is a life science company focused on drug discovery and development in partnership with pharmaceutical and biotechnology firms. The company operates an integrated research and development value chain, utilizing proprietary technology platforms that incorporate AI-driven innovation and induced pluripotent stem cells (iPSC). Its expertise spans a wide range of therapeutic modalities, from small molecules to biotherapeutics. Through its Just – Evotec Biologics division, the company offers end-to-end solutions for the design, development, and manufacturing of biologic therapies, aiming to enhance their accessibility and affordability. Evotec employs flexible partnering models to accelerate the delivery of new treatments to patients with high efficiency and quality.

Recent filings

Filing Released Lang Actions
Q3 Report 2006
Interim / Quarterly Report
2006-11-09 German
Presentation September 2006
Investor Presentation Classification · 100% confidence The document is titled 'Evotec AG: September 2006' and contains extensive slides detailing the company's CNS pipeline, specifically focusing on clinical trial results (Phase I/II proof-of-principle studies) for a drug candidate (EVT 201). It includes detailed scientific data, market analysis for insomnia treatments, and an agenda covering 'Clinical CNS Pipeline' and 'Financials and Outlook'. The structure, heavy use of figures, tables, and presentation formatting strongly indicates this is an Investor Presentation (IP) or a similar detailed presentation deck, rather than a formal regulatory filing like a 10-K, an Earnings Release (ER), or a short Report Publication Announcement (RPA). Given the content is a detailed presentation for investors covering strategy and pipeline progress, 'Investor Presentation' (IP) is the most appropriate classification.
2006-09-10 English
Q2 Report 2006
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Evotec AG, Second Quarter Report 2006'. It contains detailed financial highlights, a management discussion of business performance, pipeline updates, and comparative financial tables for the first half of 2006. It is a comprehensive interim financial report, not an announcement or a summary, and therefore fits the definition of an Interim/Quarterly Report (IR). H1 2006
2006-08-11 English
Presentation May 2006
Investor Presentation Classification · 100% confidence The document is a presentation titled 'Evotec AG: May 2006' and contains an agenda listing '01 Evotec Overview', '02 Clinical CNS Pipeline', '03 Selected Service Partnerships', and '04 Financials and Outlook'. It details clinical programs (EVT 301, EVT 101, EVT 201), preclinical data, Phase I/II results, and financial highlights from 2005. This structure, focusing on strategy, pipeline development, and financial summary, is characteristic of an Investor Presentation (IP) or a presentation given at an investor conference, rather than a formal regulatory filing like a 10-K or an Earnings Release (ER) which typically contains standardized financial statements and MD&A sections. Since it is a detailed presentation for investors, 'IP' is the most appropriate classification.
2006-05-11 English
Q1 Report 2006
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Evotec AG, First Quarter Report 2006'. It contains detailed financial performance data, including revenue breakdowns, operating results, and segment analysis for the first quarter of the fiscal year. It is a comprehensive report covering a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). Q1 2006
2006-05-11 English
Annual Report 2005
Annual Report Classification · 100% confidence The document is explicitly titled 'Evotec AG Annual Report 2005'. It contains comprehensive financial data, including consolidated financial statements, balance sheets, statements of operations, cash flows, and management's discussion and analysis for the fiscal year 2005. It meets all criteria for an Annual Report (10-K equivalent for a non-US entity). FY 2005
2006-03-30 English

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.